Table 1 Clinical variables for primary and metastatic prostate cancer samples used in this study
| Prostate Cancer Tissue Samples | No. of Samples | Number of Patients | Microarray Platform | Clinical Information | |
|---|---|---|---|---|---|
| 64 | 64 | Affymetrix | Please see reference [7] | ||
| Gleason Score | No. of Cases | ||||
| 7 | 10 | ||||
| Primary Tumors | 10 | 10 | CodeLink | Pathological Stage | No. of Cases |
| 2B | 6 | ||||
| 3A | 3 | ||||
| 3B | 1 | ||||
| Patient ID | No. of Samples | ||||
| FB6561 | 11 | ||||
| FB666 | 1 | ||||
| FB667 | 8 | ||||
| FB669 | 5 | ||||
| Metastatic Sites | No. of Samples | ||||
| Metastatic | 24 | 4 | Affymetrix | Liver | 5 |
| Para Aortic Lymph Node | 3 | ||||
| Para Tracheal Lymph Node | 8 | ||||
| Retroperitoneal Lymph Node | 3 | ||||
| Lung | 1 | ||||
| Adrenal | 2 | ||||
